Dr. George Stoica

Intensive Care Medicine
Office
100 W Gore St Ste 202, 
Orlando, FL 
Referral may be required
Office
100 W Gore St Ste 202, 
Orlando, FL 

Overview

George Stoica is an Intensive Care Medicine provider practicing medicine in Orlando, Florida.

He is actively involved in clinical research, participating in 6 clinical trials.

Specialties

Intensive Care Medicine

Licenses

Internal Medicine in NY

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO

Locations

Office
100 W Gore St Ste 202, Orlando, FL 32806

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3372993 in Participants With Alzheimer's Disease and Healthy Participants
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3372993 in Participants With Alzheimer's Disease and Healthy Participants
Enrollment Status: Completed
Publish Date: March 28, 2025
Intervention Type: Drug
Study Drug: LY3372993
Study Phase: Phase 1
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
Study Phase: Phase 2
Multiple-Dose, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3303560 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease
Multiple-Dose, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3303560 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: October 10, 2023
Intervention Type: Drug
Study Phase: Phase 1
A 4-Week, Double-blind, Placebo-controlled, Randomized, Multicenter, Crossover Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness
A 4-Week, Double-blind, Placebo-controlled, Randomized, Multicenter, Crossover Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness
Enrollment Status: Completed
Publish Date: January 09, 2020
Intervention Type: Drug, Other
Study Phase: Phase 2
A Single-Dose and Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3372993 in Healthy Subjects and Patients With Alzheimer's Disease
A Single-Dose and Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3372993 in Healthy Subjects and Patients With Alzheimer's Disease
Enrollment Status: Completed
Publish Date: June 05, 2019
Intervention Type: Drug
Study Phase: Phase 1
Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3154207 in Healthy Subjects and Subjects With Parkinson's Disease
Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3154207 in Healthy Subjects and Subjects With Parkinson's Disease
Enrollment Status: Completed
Publish Date: March 21, 2017
Intervention Type: Drug
Study Phase: Phase 1
View 5 Less Clinical Trials
Similar Doctors
Expertise in
14
conditions
Dr. Debabrata Bandyopadhyay
Intensive Care Medicine | Pulmonary Medicine
Expertise in
14
conditions
Dr. Debabrata Bandyopadhyay
Intensive Care Medicine | Pulmonary Medicine

Florida Hospital Medical Group Inc

2501 N Orange Ave, 
Orlando, FL 
 (3.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Debabrata Bandyopadhyay is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Orlando, Florida. Dr. Bandyopadhyay is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Sarcoidosis, Bone Graft, and Lung Transplant. Dr. Bandyopadhyay is currently accepting new patients.

Expertise in
15
conditions
Dr. Mark Vollenweider
Intensive Care Medicine
Expertise in
15
conditions
Dr. Mark Vollenweider
Intensive Care Medicine

Scripts Pharmacy

1222 S Orange Ave, 
Orlando, FL 
 (0.3 miles away)
321-841-7856
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Vollenweider is an Intensive Care Medicine provider practicing medicine in Orlando, Florida. Dr. Vollenweider is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Acquired Tracheomalacia, Tracheobronchomalacia, Advanced Bronchoscopy, and Gastrostomy.

Expertise in
23
conditions
Dr. Antonio Rodriguez
Intensive Care Medicine
Expertise in
23
conditions
Dr. Antonio Rodriguez
Intensive Care Medicine

Orlando Health Medical Group Inc

515 W State Road 434 Ste 203, 
Longwood, FL 
 (11.8 miles away)
407-265-7775
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Antonio Rodriguez is an Intensive Care Medicine provider practicing medicine in Longwood, Florida. Dr. Rodriguez is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Hospital-Acquired Pneumonia, Atypical Pneumonia, and Carotid Artery Surgery.

Frequently Asked Questions about Dr. George Stoica

How do I make an appointment with Dr. George Stoica?

You can book an appointment with Dr. George Stoica by calling their office at 407-426-9299. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Does Dr. George Stoica accept my insurance?

Dr. George Stoica accepts most major insurance plans, including Aetna. We recommend calling the office directly at 407-426-9299 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Stoica's expertise for a condition
ConditionClose

We do not have enough information to identify the Areas of Expertise for this provider.

Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile